ConductScience.org, home

Paper29048985

Impact of meningococcal group B OMV vaccines, beyond their brief.

Petousis-Harris H. Hum Vaccin Immunother, 2018. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Impact of meningococcal group B OMV vaccines, beyond their brief. Papers, record 29048985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29048985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of meningococcal group B OMV vaccines, beyond their brief.
PubMed
Journal
Hum Vaccin Immunother
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
2.44
iCite
Revised in PubMed
2022-04-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Petousis-Harris HHelen

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, BacterialMajor topic
Bacterial Outer Membrane ProteinsMajor topic
Meningococcal InfectionsMajor topic
Meningococcal VaccinesMajor topic
Neisseria meningitidis, Serogroup BMajor topic
Brazil
Cross Protection
Cuba
Gonorrhea
Humans
Immunogenicity, Vaccine
Incidence
Neisseria gonorrhoeae
New Zealand
Recombinant Proteins
Treatment Outcome

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in29420119Cross-protection induced by VA-MENGOC-BC® vaccine.https://conductscience.org/library/papers/29420119

Source PubMed

Download CSV of comments and corrections

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120219881
Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.
Clin Vaccine Immunol2010https://conductscience.org/library/papers/20219881PubMed
225483706Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: results from a decision-analysis model.Hum Vaccin Immunother2014https://conductscience.org/library/papers/25483706PubMed
316829618Understanding the immune responses to the meningococcal strain-specific vaccine MeNZB measured in studies of infants.Clin Vaccine Immunol2006https://conductscience.org/library/papers/16829618PubMed
415755595The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.Vaccine2005https://conductscience.org/library/papers/15755595PubMed
54977280Human immunity to the meningococcus. I. The role of humoral antibodies.J Exp Med1969https://conductscience.org/library/papers/4977280PubMed
67591118Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.Infect Immun1995https://conductscience.org/library/papers/7591118PubMed
71812432Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.NIPH Ann1991https://conductscience.org/library/papers/1812432PubMed
828207068Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.Clin Infect Dis2017https://conductscience.org/library/papers/28207068PubMed
928686231Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.PLoS Med2017https://conductscience.org/library/papers/28686231PubMed
1016825336A universal vaccine for serogroup B meningococcus.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16825336PubMed
1120844462Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.Pediatr Infect Dis J2010https://conductscience.org/library/papers/20844462PubMed
1228557577The next chapter for group B meningococcal vaccines.Crit Rev Microbiol2018https://conductscience.org/library/papers/28557577PubMed
1315385499Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.Infect Immun2004https://conductscience.org/library/papers/15385499PubMed
1426192351The potential impact of vaccination on the prevalence of gonorrhea.Vaccine2015https://conductscience.org/library/papers/26192351PubMed
1528705462Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.Lancet2017https://conductscience.org/library/papers/28705462PubMed
161682541Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.Lancet1991https://conductscience.org/library/papers/1682541PubMed
1717227687Induction of secretory immunity and memory at mucosal surfaces.Vaccine2007https://conductscience.org/library/papers/17227687PubMed
1817898183Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.Clin Vaccine Immunol2007https://conductscience.org/library/papers/17898183PubMed
1917615088A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.Am J Epidemiol2007https://conductscience.org/library/papers/17615088PubMed
2017494636Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.Clin Vaccine Immunol2007https://conductscience.org/library/papers/17494636PubMed

See all 38 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
42373756New insights into outer membrane vesicles in Gram-negative bacteria from biogenesis to applications.Commun Biol2026https://conductscience.org/library/papers/42373756PubMed
42343418Bacterial extracellular vesicles modulate epithelial antiviral responses via macrophage-mediated immunomodulation.Cell Commun Signal2026https://conductscience.org/library/papers/42343418PubMed
42321851Extracellular vesicles in solid tumors: from tumor ecology to engineered therapeutics.Mol Cancer2026https://conductscience.org/library/papers/42321851PubMed
41900446Bacterial Membrane Vesicles: Biogenesis, Functions, and Emerging Biotechnological Applications.Microorganisms2026https://conductscience.org/library/papers/41900446PubMed
41810466From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinics.Asian J Pharm Sci2026https://conductscience.org/library/papers/41810466PubMed
41572344Bacterial outer membrane vesicles: a smart platform for biomedical applications.Cell Commun Signal2026https://conductscience.org/library/papers/41572344PubMed
41169343Two Sides of the Same Coin-Mechanistic Insight, Diagnostic Application and Therapeutic Translation of Bacterial and Host-Derived Extracellular Vesicles.J Extracell Biol2025https://conductscience.org/library/papers/41169343PubMed
41050659Gut microbiota: a promising new target in immune tolerance.Front Immunol2025https://conductscience.org/library/papers/41050659PubMed
40617825A novel GMMA-based gonococcal vaccine demonstrates functional immune responses in mice.NPJ Vaccines2025https://conductscience.org/library/papers/40617825PubMed
40430807Genetic and Antigenic Diversity of Neisseria meningitidis Serogroup B Strains in Vietnam.Pathogens2025https://conductscience.org/library/papers/40430807PubMed
40192813Optimization of methods for isolation and purification of outer membrane vesicles (OMVs) from Neisseria lactamica.Appl Microbiol Biotechnol2025https://conductscience.org/library/papers/40192813PubMed
39923096RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2.J Nanobiotechnology2025https://conductscience.org/library/papers/39923096PubMed
38939213Large-scale production of extracellular vesicles: Report on the "massivEVs" ISEV workshop.J Extracell Biol2022https://conductscience.org/library/papers/38939213PubMed
38773507Outer membrane vesicles generated by an exogenous bacteriophage lysin and protection against Acinetobacter baumannii infection.J Nanobiotechnology2024https://conductscience.org/library/papers/38773507PubMed
38289395Modelling of doxycycline-based prevention of bacterial sexually transmitted infections in comparison to condom-based and test-based prevention.Eur J Microbiol Immunol (Bp)2024https://conductscience.org/library/papers/38289395PubMed
37651146Association of Group B Meningococcal Vaccine Receipt With Reduced Gonorrhea Incidence Among University Students.JAMA Netw Open2023https://conductscience.org/library/papers/37651146PubMed
37223254Outer membrane vesicles as versatile tools for therapeutic approaches.Microlife2021https://conductscience.org/library/papers/37223254PubMed
37222309Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease.Mem Inst Oswaldo Cruz2023https://conductscience.org/library/papers/37222309PubMed
37080941Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37080941PubMed
36986523Endogenous Lipid Carriers-Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/36986523PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29048985

GET https://conductscience.org/api/papers/v1/29048985/references?page=2